Related Experiment Videos

Antibody response following measles-mumps-rubella vaccine under conditions of customary use

JAMA
|September 16, 1983
PubMed

Insights

A single dose of measles, mumps, and rubella (MMR) vaccine provides high immunity in children. Over 98% of vaccinated children showed antibodies, confirming vaccine effectiveness for disease prevention.

Area of Science:

  • Pediatrics
  • Immunology
  • Vaccinology

Background:

  • Measles, mumps, and rubella (MMR) are significant childhood diseases.
  • Vaccination is a primary method for preventing these viral infections.

Purpose of the Study:

  • To evaluate the immunogenicity of the MMR vaccine in a pediatric population.
  • To assess the effectiveness of a single MMR vaccine dose in conferring immunity.

Main Methods:

  • Serological testing of 301 children previously immunized with MMR vaccine.
  • Antibody levels against measles, mumps, and rubella were measured.
  • Control group of 49 unvaccinated infants tested for pre-existing antibodies.

Main Results:

  • 99.7% of children had rubella antibodies; 98.3% had measles and mumps antibodies.
  • No unvaccinated infants showed antibodies, ruling out prior infection or false positives.
  • High antibody prevalence confirmed the vaccine's immunogenic potential.

Conclusions:

  • A single dose of the MMR vaccine is highly effective.
  • Standard MMR vaccination confers robust immunity against measles, mumps, and rubella.
  • The vaccine is a reliable method for preventing these diseases in children.

Related Concept Videos